2012•Heilongjiang Medical JournalRequires access

Ebastine Combined BCG-PSN in the Treatment of Chronic Urticaria

Hong Mei-lan

Abstract

Objective To investigate the effect and safety of ebastine combined BCG-PSN in the treatment of chronic urticaria. Methods 363 patients with chronic urticaria were divided into two groups,treatment group was 189 cases,ebastine 10 mg once a day oral administration,BCG-PSN 0.7 mg,intramuscular injection once a day.Control group was 174 cases,ebastine 10 mg once a day oral administration.Four weeks as a course.After each treatment course reduced the amount of ebastine.Five courses end of treatment. Results The total score in the treatment group was better than in the control group(P0.05),Treatment group was 63.8% efficiency,no significant side effects. Conclusion BCG-PSN combined ebastine mightbe satisfactory and safe in the treatment of chronic urticaria.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Chronic urticaria, Oral administration, Intramuscular injection, Anesthesia, Dermatology, Internal medicine